Related references
Note: Only part of the references are listed.Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities
Arwa Z. Al-Riyami et al.
VOX SANGUINIS (2021)
Coronavirus Disease 2019 (COVID-19) A Perspective from China
Zi Yue Zu et al.
RADIOLOGY (2020)
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh et al.
NATURE COMMUNICATIONS (2020)
Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
Balamurugan Shanmugaraj et al.
PATHOGENS (2020)
COVID-19: Developing from an Outbreak to A Pandemic
Sara Hanaei et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections
Robert C. Speth
DRUG DEVELOPMENT RESEARCH (2020)
Immune-epidemiological parameters of the novel coronavirus - a perspective
Amene Saghazadeh et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
Pierre Tiberghien et al.
VOX SANGUINIS (2020)
COVID-19 and lung cancer: risks, mechanisms and treatment interactions
Alfredo Addeo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The possible of immunotherapy for COVID-19: A systematic review
Akram AminJafari et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Marisa Market et al.
FRONTIERS IN IMMUNOLOGY (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences
Melika Lotfi et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Monoclonal antibody as a potential anti-COVID-19
Leila Jahanshahlu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi et al.
CLINICA CHIMICA ACTA (2020)
The immune system and COVID-19: Friend or foe?
Fereshteh Yazdanpanah et al.
LIFE SCIENCES (2020)
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
Srinivasa Reddy Bonam et al.
CELL REPORTS MEDICINE (2020)
Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Zikuan Leng et al.
AGING AND DISEASE (2020)
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants
JH Sui et al.
JOURNAL OF VIROLOGY (2005)
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus
EN van den Brink et al.
JOURNAL OF VIROLOGY (2005)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
